VerifyRecall
Alerts
RECALL RECORD — CLASS IRecall closedF-0721-2025/FDA enforcement
New York Wholesale Group·Food·Mar 10, 2025

Zaarah Herbals Brand Bhringraj Powder

What you need to know

Class I

  • What happened

    Products contain elevated levels of Lead (Pb): 3.231 ppm and Arsenic (As): 0.958 ppm;

  • Health risk

    The product has a reasonable probability of causing serious adverse health consequences or death. Lead is a toxic heavy metal with no safe blood lead level in children.

  • Action required

    Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice.

Recall closed · classified by the FDANY, CT, NJ, CAMore food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Share via WhatsApp

Match before you discard

Product identification

Source: FDA FOOD

Brand nameNew York Wholesale Group
Recalling firmNew York Wholesale GroupHicksville, NY, United States
UPC / barcodes
6 35028 99973 1
Lot / date codes
  • Batch No: BJ 04 Mfd. Date: July / 2022
Distribution area
NYCTNJCA

NY, CT, NJ, CA

United States

Quantity affected46.98 cases total
Recall initiationFDA report date: April 30, 2025
FDA recall numberF-0721-2025

Beyond the headline

The recall, in context

New York Wholesale Group initiated this food recall on March 10, 2025. The FDA enforcement report states: Products contain elevated levels of Lead (Pb): 3.231 ppm and Arsenic (As): 0.958 ppm;. The FDA report lists distribution as: NY, CT, NJ, CA.

The FDA enforcement report describes the reason as: Products contain elevated levels of Lead (Pb): 3.231 ppm and Arsenic (As): 0.958 ppm;

Zaarah Herbals Brand Bhringraj Powder was made or distributed by New York Wholesale Group in Hicksville, NY, United States. This page reflects FDA report F-0721-2025, dated April 30, 2025.

Why this is a Class I recall

Class I means the product has a reasonable probability of causing serious adverse health consequences or death. In this recall, lead is a toxic heavy metal with no safe blood lead level in children.

FDA definition

The product has a reasonable probability of causing serious adverse health consequences or death.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the UPC and lot code against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Lead contamination

Possible health effects

Lead can affect the nervous system and is especially harmful to children and pregnant people. Symptoms may include abdominal pain, constipation, fatigue or headaches, but some exposed people have no obvious symptoms.

When symptoms may appear

Health effects depend on the amount and duration of exposure; there is no safe blood lead level in children.

Higher-risk groups

Infants, young children, pregnant people and anyone with repeated exposure are at greatest risk.

What to do now

  1. 1Stop using or eating the affected product and prevent children from handling it.
  2. 2Keep the packaging and ask the retailer or manufacturer about a refund; follow local guidance for safe disposal.
  3. 3If a child or pregnant person may have been exposed, contact a healthcare professional about blood lead testing.

Do not use home remedies or ignore possible exposure; clinical testing is the appropriate next step.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Zaarah Herbals Brand Bhringraj Powder recall?

New York Wholesale Group recalled Zaarah Herbals Brand Bhringraj Powder in an FDA Class I enforcement action reported as F-0721-2025. Products contain elevated levels of Lead (Pb): 3.231 ppm and Arsenic (As): 0.958 ppm;

What should I do if I bought this product?

Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice. Stop using or eating the affected product and prevent children from handling it. Keep the packaging and ask the retailer or manufacturer about a refund; follow local guidance for safe disposal. If a child or pregnant person may have been exposed, contact a healthcare professional about blood lead testing.

Is the New York Wholesale Group recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-0721-2025. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by New York Wholesale Group

View brand
Class I·

New York Wholesale Group

Zaarah Herbals Brand Gurmar Powder

Products contain elevated levels of Lead (Pb): 3.688 ppm

NY, CT, NJ +1 moreFood
Class I·

New York Wholesale Group

Zaarah Herbals Brand Rasayan Churan

Products contain elevated levels of Lead (Pb): 88.038 ppm

NY, CT, NJ +1 moreFood

Related alerts

Recent Lead recalls

All alerts
Class II·

Pacific Coast Producers

Great Value Fruit Cocktail in Fruit Juice from Concentrate NET WT 15 OZ (425g) Distributed by: …

Potential contamination with elevated levels of lead.

AL, AZ, LA +4 moreFood
Class II·

Galil Importing Corp

Lior Brand Cinnamon Ground Seasoning

Product contains elevated levels of lead.

NY, NJ, PA +3 moreFood

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.